IP Library › Assignment 027712/0200
Patent Assignment
Reel/Frame 027712/0200

Security Agreement

Recorded: 2012-02-15 Received: 2012-02-15 Pages: 65
Assignors
CEQUENT PHARMACEUTICALS, INC.
Executed: 2012-02-10
MARINA BIOTECH, INC
Executed: 2012-02-10
MDRNA RESEARCH, INC.
Executed: 2012-02-10
Assignee
GENESIS CAPITAL MANAGEMENT, LLC, AS AGENT
332 PINE STREET, SAN FRANCISCO, CA, 94104, UNITED STATES
Covered Properties (97)
Amphoteric Liposomes Comprising Imino Lipids
Application: 13/378,484 →
Amphoteric Liposomes, A Method Of Formulating An Amphoteric Liposome And A Method Of Loading An Amphoteric Liposome
Application: 13/350,137 →
Nucleic Acid Compounds for Inhibiting Gene Expression and Uses Thereof
Application: 13/327,545 →
Compositions for Intranasal Delivery of Human Insulin and Uses Thereof
Application: 13/314,080 →
Components for Producing Amphoteric Liposomes
Application: 13/291,650 →
Synthesis and Uses of Nucleic Acid Compounds with Conformationally Restricted Monomers
Application: 61/532,056 →
Una Oligomer Structures for Therapeutic Agents
Application: 13/130,032 →
Compositions for Bacterial Mediated Gene Silencing and Methods of Using Same
Application: 13/196,436 →
Nucleic Acid Compounds for Inhibiting BIRC5 Gene Expression and Uses Thereof
Application: 13/057,741 →
Nucleic Acid Compounds for Inhibiting FGFR3 Gene Expression and Uses Thereof
Multi-Sirna Compositions for Reducing Gene Expression
Nucleic Acid Compounds with Conformationally Restricted Monomers and Uses Thereof
Nucleic Acid Compounds for Inhibiting Hras Gene Expression and Uses Thereof
Amino Acid Lipids and Uses Thereof
Application: 13/076,158 →
Nucleic Acid Compounds for Inhibiting Survivin Gene Expression Uses Thereof
Modified Forms of Nucleic Acid Compounds and Uses Thereof
Application: 61/467,048 →
Nucleic Acid Compounds for Inhibiting PLK1 Gene Expression and Uses Thereof
Application: 13/057,743 →
Activity Generating Delivery Molecules
Amphoteric liposomes
Application: 12/807,707 →
Methods and Compositions for Enhancing Delivery of Double-Stranded Rna or a Double-Stranded Hybrid Nucleic Acid to Regulate Gene Expression in Mammalian Cells
Application: 12/870,989 →
Amphoteric liposomes
Application: 12/806,342 →
Amphoteric Liposomes Comprising Neutral Lipids
Application: 12/682,703 →
Bacterial Mediated Tnf Alpha Gene Silencing
Application: 12/602,883 →
Multi-Sirna Compositions for Reducing Gene Expression
Application: 61/329,034 →
Modified Forms of Nucleic Acid Compounds and Uses Thereof
Application: 61/328,140 →
Nucleic Acid Compounds for Inhibiting Hras Gene Expression and Uses Thereof
Application: 61/325,757 →
Lipopeptides for Delivery of Nucleic Acids
Application: 12/750,622 →
Nucleic Acid Compounds for Inhibiting Survivin Gene Expression and Uses Thereof
Application: 61/318,141 →
Gras Composition for Intranasal Delivery of Parathyroid Hormone
Application: 12/726,315 →
Compositions and Methods for Enhanced Mucosal Delivery of Parathyroid Hormone
Application: 12/726,308 →
Intranasal Administration of Rapid Acting Insulin
Application: 12/672,478 →
Phage Displayed Cell Binding Peptides
Application: 12/701,397 →
Bacteria Mediated Gene Silencing
Application: 12/632,985 →
Usirna Complexes
E. Coli Mediated Gene Silencing of Beta-Catenin
Amino Acid-Based Nanoparticle Formulations
Application: 61/258,115 →
Processes and Compositions for Liposomal and Efficient Delivery of Gene Silencing Therapeutics
Rna Complexes Comprising Acyclic Nucleomonomers
Application: 61/252,085 →
Construction and Use of Transfection Enhancer Elements
Application: 12/448,452 →
Nucleic Acid Compounds for Inhibiting Gene Expression and Uses Thereof
Application: 12/552,082 →
Nucleic Acid Compounds for Inhibiting Wnt Gene Expression and Uses Thereof
Application: 12/529,532 →
Nucleic Acid Compounds for Inhibiting Ras Gene Expression and Uses Thereof
Application: 12/529,302 →
Nucleic Acid Compounds for Inhibiting Myc Gene Expression and Uses Thereof
Application: 12/529,138 →
Nucleic Acid Compounds for Inhibiting BCL2 Gene Expression and Uses Thereof
Application: 12/529,011 →
Nucleic Acid Compounds for Inhibiting HIF1A Gene Expression and Uses Thereof
Application: 12/528,786 →
Nucleic Acid Compounds for Inhibiting Erbb Family Gene Expression and Uses Thereof
Application: 12/528,619 →
Nucleic Acid Compounds for Inhibiting Vegf Family Gene Expression and Uses Thereof
Application: 12/528,508 →
Nucleic Acid Compounds for Inhibiting BIRC5 Gene Expression and Uses Thereof
Nucleic Acid Compounds for Inhibiting PLK1 Gene Expression and Uses Thereof
Hydroxymethyl Substituted Rna Oligonucleotides and Rna Complexes
Application: 12/515,403 →
Nicked or Gapped Nucleic Acid Molecules and Uses Thereof
Application: 12/445,868 →
Compounds and Methods for Peptide Ribonucleic Acid Condensate Particles for Rna Therapeutics
Application: 12/445,575 →
Compositions and Methods for Efficient Delivery of Gene Silencing Therapeutics
Application: 61/167,379 →
Amphoteric Liposome Formulation
Application: 12/085,893 →
Efficient Method For Loading Amphoteric Liposomes With Nucleic Acid Active Substances
Application: 12/225,030 →
Compositions for Intranasal Delivery of Human Insulin and Uses Thereof
Application: 12/376,205 →
Rna Oligonucleotides and Rna Complexes Comprising Acyclic Nucleomonomers
Application: 61/119,624 →
Bacteria Mediated Gene Silencing
Application: 61/114,610 →
Compositions and Methods for Liposomal Rna Therapeutics
Application: 61/106,062 →
Lipopeptides for Delivery of Nucleic Acids
Compositions for Enhanced Epithelial Permeation of Neuropeptide Y for Treating Obesity
Application: 12/234,547 →
Compositions and Methods for Enhancing Delivery of Nucleic Acids into Cells and for Modifying Expression of Target Genes in Cells
Application: 12/206,165 →
Serum-Stable Amphoteric Liposomes
Application: 10/594,553 →
Nucleic Acid Compounds for Inhibiting PLK1 Gene Expression and Uses Thereo
Application: 61/086,445 →
Nucleic Acid Compounds for Inhibiting BIRC5 Gene Expression and Uses Thereof
Application: 61/086,435 →
Bacterial Mediated Tnf-a Gene Silencing
Bacteria Mediated Gene Silencing
Hydroxymethyl Substituted Rna Oligonucleotides and Rna Complexes
Amino Acid Lipids and Uses Thereof
Nucleic Acid Compounds for Inhibiting Myc Gene Expression and Uses Thereof
Nucleic Acid Compounds for Inhibiting Wnt Gene Expression and Uses Thereof
Nucleic Acid Compounds for Inhibiting Ras Gene Expression and Uses Thereof
Nucleic Acid Compounds for Inhibiting BCL2 Gene Expression and Uses Thereof
Nucleic Acid Compounds for Inhibiting Akt Gene Expression and Uses Thereof
Nucleic Acid Compounds for Inhibiting Vegf Gene Expression and Uses Thereof
Application: 12/039,650 →
Nucleic Acid Compounds for Inhibiting Apob Gene Expression and Uses Thereof
Application: 12/039,668 →
Nucleic Acid Compounds for Inhibiting Vegf Family Gene Expression and Uses Thereof
Nucleic Acid Compounds for Inhibiting Akt Gene Expression and Uses Thereof
Application: 12/039,662 →
Nucleic Acid Compounds for Inhibiting Erbb Gene Expression and Uses Thereof
Application: 12/039,658 →
Nucleic Acid Compounds for Inhibiting HIF1A Gene Expression and Uses Thereof
File Conversion in Restricted Process
Dispersion Compositions for Interfering Rna and Uses Thereof
Application: 61/022,571 →
Bacteria mediated gene silencing
Application: 61/010,028 →
Nucleic Acid Compounds for Inhibiting WNT3A Gene Expression and Uses Thereof
Application: 61/015,611 →
Lipids and Lipid Assemblies Comprising Transfection Enhancer Elements
Application: 12/004,154 →
Nucleic Acid Compounds for Inhibiting AKT3 Gene Expression and Uses Thereof
Application: 61/013,239 →
Nucleic Acid Compounds for Inhibiting AKT2 Gene Expression and Uses Thereof
Application: 61/013,212 →
Phage Displayed Trp Cage Ligands
Application: 11/955,207 →
Nucleic Acid Compounds for Inhibiting BCL2 Gene Expression and Uses Thereof
Application: 60/989,419 →
Nucleic Acid Compounds for Inhibiting Nras Gene Expression and Uses Thereof
Application: 60/988,400 →
Nucleic Acid Compounds for Inhibiting Kras Gene Expression and Uses Thereof
Application: 60/988,402 →
Nucleic Acid Compounds for Inhibiting Myc Gene Expression and Uses Thereof
Application: 60/988,395 →
Nucleic Acid Compounds for Inhibiting Hras Gene Expression and Uses Thereof
Application: 60/988,401 →
Nicked or Gapped Nucleic Acid Molecules and Uses Thereof
Lipopeptides for Delivery of Interfering Rna Agents
Application: 60/976,894 →
Genetic inhibition by double-stranded RNA
Application: 11/905,449 →
Genetic Inhibition of Double-Stranded Rna
Application: 11/905,368 →